Professor Bridget A. Robinson

Journal - Research Article

Lattimore, V. L., Pearson, J. F., Morley-Bunker, A. E., kConFab Investigators, Spurdle, A. B., Robinson, B. A., Currie, M. J., & Walker, L. C. (2019). Quantifying BRCA1 and BRCA2 mRNA isoform expression levels in single cells. International Journal of Molecular Sciences, 20(3), 693. doi: 10.3390/ijms20030693

Robinson, B., Dijkstra, B., Davey, V., Tomlinson, S., & Frampton, C. (2018). Adherence to adjuvant endocrine therapy in Christchurch women with early breast cancer. Clinical Oncology, 30(1), e9-e15. doi: 10.1016/j.clon.2017.10.015

James, M., Swadi, S., Yi, M., Johansson, L., Robinson, B., & Dixit, A. (2018). Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series. Journal of Medical Imaging & Radiation Oncology, 62(3), 425-431. doi: 10.1111/1754-9485.12712

Buchwald, P., Hall, C., Davidson, C., Dixon, L., Dobbs, B., Robinson, B., & Frizelle, F. (2018). Improved survival for rectal cancer compared to colon cancer: The four cohort study. ANZ Journal of Surgery, 88(3), E114-E117. doi: 10.1111/ans.13730

James, M., Dixit, A., Robinson, B., Frampton, C., & Davey, V. (2018). Outcomes for patients with non-metastatic triple-negative breast cancer in New Zealand. Clinical Oncology. Advance online publication. doi: 10.1016/j.clon.2018.09.006

Wohlrab, C., Vissers, M. C. M., Phillips, E., Morrin, H., Robinson, B. A., & Dachs, G. U. (2018). The association between ascorbate and the hypoxia-inducible factors in human renal cell carcinoma requires a functional von Hippel-Lindau protein. Frontiers in Oncology, 8, 574. doi: 10.3389/fonc.2018.00574

James, M., McLean, G., Williams, S., Robinson, B., & Yi, M. (2018). Complications of curative radiation treatment for early prostate cancer. Asia-Pacific Journal of Clinical Oncology, 14(5), e392-e398. doi: 10.1111/ajco.12839

Lattimore, V. L., Pearson, J. F., Currie, M. J., Spurdle, A. B., kConFab Investigators, Robinson, B. A., & Walker, L. C. (2018). Investigation of experimental factors that underlie BRCA1/2 mRNA isoform expression variation: Recommendations for utilising targeted RNA sequencing to evaluate potential spliceogenic variants. Frontiers in Oncology, 8, 140. doi: 10.3389/fonc.2018.00140

Robinson, B., Currie, M., Phillips, E., Dachs, G., Strother, M., Morrin, H., Davey, V., & Frampton, C. (2017). Body mass index (BMI): Association with clinicopathological factors and outcome of women with newly diagnosed breast cancer in New Zealand. New Zealand Medical Journal, 130(1451), 46-56. Retrieved from https://www.nzma.org.nz/journal

Fernando, C., Frizelle, F., Wakeman, C., Frampton, C., & Robinson, B. (2017). Colorectal multidisciplinary meeting audit to determine patient benefit. ANZ Journal of Surgery, 87(11), E173-E177. doi: 10.1111/ans.13366

James, M. L., Dehn, G., & Robinson, B. A. (2016). Hypofractionated radiation treatment in early breast cancer: Results in a New Zealand setting. Asia-Pacific Journal of Clinical Oncology, 12, 248-253. doi: 10.1111/ajco.12458

van Hazel, G. A., Heinemann, V., Sharma, N. K., Findlay, M. P. N., Ricke, J., Peeters, M., Perez, D., Robinson, B. A., … Gibbs, P. (2016). SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 34(15), 1723-1731. doi: 10.1200/JCO.2015.66.1181

Campbell, E. J., Vissers, M. C. M., Wohlrab, C., Hicks, K. O., Strother, R. M., Bozonet, S. M., Robinson, B. A., & Dachs, G. U. (2016). Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice. Free Radical Biology & Medicine, 99, 451-462. doi: 10.1016/j.freeradbiomed.2016.08.027

Campbell, E. J., Vissers, M. C. M., Bozonet, S., Dyer, A., Robinson, B. A., & Dachs, G. U. (2015). Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo^−/− mice. Cancer Medicine, 4(2), 303-314. doi: 10.1002/cam4.349

Dachs, G. U., Phillips, E., Phung, Y., Dyer, A., Willis, J. A., Currie, M. J., & Robinson, B. A. (2015). Tumour growth in mice resistant to diet-induced obesity. Journal of Molecular Biochemistry, 4(2), 42-49.

Kuchenbaecker, K. B., Ramus, S. J., Tyrer, J., Lee, A., Shen, H. C., Beesley, J., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … for the Consortium of Investigators of Modifiers of BRCA1 and BRCA2. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics, 47(2), 164-171. doi: 10.1038/ng.3185

Gerring, Z., Pearson, J. F., Morrin, H. R., Robinson, B. A., Harris, G. C., & Walker, L. C. (2015). Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients. Histopathology, 67(4), 538-547. doi: 10.1111/his.12678

Price, T. J., Bruhn, M. A., Lee, C. K., Hardingham, J. E., Townsend, A. R., Mann, K. P., … Robinson, B., … Tebbutt, N. C. (2015). Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX study involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer. British Journal of Cancer, 112, 963-970. doi: 10.1038/bjc.2015.37

Ko, D.-H. I., Norriss, A., Harrington, C. R., Robinson, B. A., & James, M. L. (2015). Hypofractionated radiation treatment following mastectomy in early breast cancer: The Christchurch experience. Journal of Medical Imaging & Radiation Oncology, 59, 243-247. doi: 10.1111/1754-9485.12242

Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Easton, D. F. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Geoscience, 47, 373-380. doi: 10.1038/ng.3242

Richardson, A. K., Currie, M. J., Robinson, B. A., Morrin, H., Phung, Y., Pearson, J. F., … Walker, L. C. (2015). Cytomegalovirus and Epstein-Barr Virus in breast cancer. PLoS ONE, 10(2), e0118989. doi: 10.1371/journal.pone.0118989

Perry, J. R. B., Day, F., Elks, C. E., Sulem, P., Thompson, D. J., Ferreira, T., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Ong, K. K. (2014). Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature, 514, 92-97. doi: 10.1038/nature13545

Valle, J. W., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., … Robinson, B. A., … Büchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: Ongoing lessons from the ESPAC-3 study. Journal of Clinical Oncology, 32, 504-512. doi: 10.1200/JCO.2013.50.7657

Volkova, E., Robinson, B. A., Willis, J., Currie, M. J., & Dachs, G. U. (2014). Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells. Oncology Letters, 7(2), 311-320. doi: 10.3892/ol.2013.1710

Jackson, C. G. C. A., Sharples, K., Thompson, P. I., O'Donnell, A., Robinson, B. A., Perez, D. J., … Findlay, M. P. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: A multi-centre phase II study. BMC Cancer, 14, 737. doi: 10.1186/1471-2407-14-737

Davey, V. C. L., Harris, G., Dijkstra, B., James, M., & Robinson, B. (2014). A review of the Christchurch Hospital Breast Cancer Service in 2012: Meeting the new Tumour Standards. New Zealand Medical Journal, 127(1399). Retrieved from http://www.nzma.org.nz/journal

Kuiper, C., Dachs, G. U., Munn, D., Currie, M. J., Robinson, B. A., Pearson, J. F., & Vissers, M. C. M. (2014). Increased tumour ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer. Frontiers in Oncology, 4, 10. doi: 10.3389/fonc.2014.00010

Bidwell, S., Simpson, A., Sullivan, R., Robinson, B., Thomas, W., Jackson, C., … Clarke, T. (2013). A workforce survey of New Zealand medical oncologists. New Zealand Medical Journal, 126(1371). Retrieved from http://www.nzma.org.nz/journal

Morrin, H. R., & Robinson, B. A. (2013). Sustaining a biobank through a series of earthquake swarms: Lessons learned from our New Zealand experience. Biopreservation & Biobanking, 11(4), 211-215. doi: 10.1089/bio.2013.0033

Walker, L. C., McDonald, M., Wells, J. E., Harris, G. C., Robinson, B. A., & Morris, C. M. (2013). Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma. PLoS ONE, 8(7), e70790. doi: 10.1371/journal.pone.0070790

Currie, M. J., Beardsley, B. E., Harris, G. C., Gunningham, S. P., Dachs, G. U., Dijkstra, B., Morrin, H. R., Wells, J. E., & Robinson, B. A. (2013). Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: Relationships with markers of tumor hypoxia and microvascularity. Human Pathology, 44(3), 402-411. doi: 10.1016/j.humpath.2012.06.004

Edwards, A. L., Gunningham, S. P., Clare, G. C., Hayman, M. W., Smith, M., Frampton, C. M. A., Robinson, B. A., Troughton, R. W., & Beckert, L. E. L. (2013). Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension. Respirology, 18(8), 1271-1277. doi: 10.1111/resp.12152

Lim, M., Sharma, P., Ing, A., Blackburne, H., Robinson, B., Dixon, L., Frampton, C., & Frizelle, F. (2013). Continued progress with stage III colorectal cancer: A triple cohort study. New Zealand Medical Journal, 126(1382). Retrieved from http://www.nzma.org.nz/journal

Price, T. J., Zannino, D., Wilson, K., Simes, R. J., Cassidy, J., van Hazel, G. A., Robinson, B. A., … Tebbutt, N. C. (2012). Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: A subgroup analysis from the AGITG MAX trial: An international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C. Annals of Oncology, 23(6), 1531-1536. doi: 10.1093/annonc/mdr488

Hunt, M. A., Li, D., Hay, M. P., Currie, M. J., Robinson, B. A., Patterson, A. V., & Dachs, G. U. (2012). Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro. Journal of Gene Medicine, 14(1), 62-74. doi: 10.1002/jgm.1635

Hock, B. D., Mackenzie, K. A., Cross, N. B., Taylor, K. G., Currie, M. J., Robinson, B. A., Simcock, J. W., & McKenzie, J. L. (2012). Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells. Nephrology Dialysis Transplantation, 27(1), 402-410. doi: 10.1093/ndt/gfr264

Davey, V., Robinson, B., Dijkstra, B., & Harris, G. (2012). The Christchurch Breast Cancer Patient Register: The first year. New Zealand Medical Journal, 125(1360). Retrieved from http://www.nzma.org.nz/journal

Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011). Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. British Journal of Cancer, 104, 51-59. doi: 10.1038/sj.bjc.6606005

Zhi, J., Chen, E., Major, P., Burns, I., Robinson, B., McKendrick, J., … Goldstein, D. (2011). A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer. Cancer Chemotherapy & Pharmacology, 68(5), 1199-1206. doi: 10.1007/s00280-011-1606-z

MacKenzie, K. A., Miller, A. P., Hock, B. D., Gardner, J., Simcock, J. W., Roake, J. A., Dachs, G. U., Robinson, B. A., & Currie, M. J. (2011). Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Histopathology, 58(6), 875-885. doi: 10.1111/j.1365-2559.2011.03845.x

Hunt, M. A., Currie, M. J., Robinson, B. A., & Dachs, G. U. (2010). Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents. Journal of Biomolecular Techniques, 21, 66-72.

Tebbutt, N. C., Wilson, K., Gebski, V. J., Cummins, M. M., Zannino, D., van Hazel, G. A., Robinson, B., … Price, T. J. (2010). Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study. Journal of Clinical Oncology, 28(19), 3191-3198. doi: 10.1200/JCO.2009.27.7723

Mackenzie, K. A., Wells, J. E., Lynn, K. L., Simcock, J. W., Robinson, B. A., Roake, J. A., & Currie, M. J. (2010). First and subsequent nonmelanoma skin cancers: Incidence and predictors in a population of New Zealand renal transplant recipients. Nephrology Dialysis Transplantation, 25, 300-306. doi: 10.1093/ndt/gfp482

Dachs, G. U., Kano, M., Volkova, E., Morrin, H. R., Davey, V. C. L., Harris, G. C., … Frampton, C., Currie, M. J., Wells, J. E., & Robinson, B. A. (2010). A profile of prognostic and molecular factors in European and Māori breast cancer patients. BMC Cancer, 10, 543. doi: 10.1186/1471-2407-10-543

Chin, P. K. L., Beckert, L. E. L., Gunningham, S., Edwards, A. L., & Robinson, B. A. (2009). Audit of anticoagulant thromboprophylaxis in hospitalized oncology patients. Internal Medicine Journal, 39(12), 819-825. doi: 10.1111/j.1445-5994.2008.01828.x

Walker, L. C., Harris, G. C., Wells, J. E., Robinson, B. A., & Morris, C. M. (2008). Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies. Genes Chromosomes & Cancer, 47(5), 405-417. doi: 10.1002/gcc.20545

Dachs, G. U., Currie, M. J., Mckenzie, F., Jeffreys, M., Cox, B., Foliaki, S., … Robinson, B. A. (2008). Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people. Lancet Oncology, 9(5), 473-484. doi: 10.1016/S1470-2045(08)70127-X

Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., … McCredie, M., … and also Fleming, J., Gardner, M., George, P., Reeve, T., & Robinson, B. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1095. doi: 10.1038/nature05887